P.M. Case 1: Complex Multivessel PCI
The Emory Percutaneous Intervention Course is the longest running annual interventional cardiology event in the world. Based on the teachings of founder Dr. Andreas Gruentzig, EPIC has provided...Read More
The Emory Percutaneous Intervention Course is the longest running annual interventional cardiology event in the world. Based on the teachings of founder Dr. Andreas Gruentzig, EPIC has provided training for thousands of interventional cardiologists from the United States and abroad since 1981.
The meeting’s mission is to engage interventional cardiologists and cardiac surgeons specializing in coronary and structural heart disease to further enhance the care of their patients, mentor and train future generations of cardiovascular specialists, and lead front-line clinical research in the field.
Dimitrios Karmpaliotis, MD, PhD is a member of the Center for Interventional Vascular Therapy at Columbia University...
Dimitrios Karmpaliotis, MD, PhD is a member of the Center for Interventional Vascular Therapy at Columbia University Medical Center since 2014. He has served as the director of Chronic Total Occlusions, Complex and High Risk Angioplasty Program at NYPH/CUMC and is an Associate Professor of Medicine at Columbia University Medical School. Dr. Karmpaliotis graduated from the University of Athens School of Health Sciences in Greece (1996). He trained in Internal Medicine at Brown University School of Medicine, Critical Care Medicine at Massachusetts General Hospital and Brigham and Women's Hospital (Harvard Medical School). He then trained in Cardiology at Beth Israel Deaconess Medical Center (Harvard Medical School) and Interventional Cardiology at Emory University. Before coming to Columbia University, Dr. Karmpaliotis was instrumental in building a world-class interventional cardiology program at Piedmont Heart Center in Atlanta, Georgia. Dr. Karmpaliotis has served as principal investigator on more than 50 clinical trials, and has more than 200 publications in peer-reviewed journals, with special interest in the development of techniques for treating chronic total occlusions in coronary arteries, Left Main Interventions and Advanced Hemodynamic Support. As part of the CIVT faculty, Dr. Karmpaliotis developed master-technician training programs, co-directed the complex coronary fellowship program at NYPH/CUMC, and has been an associate director of Transcatheter Cardiovascular Therapeutic Conference, as well as a co-director of the CTO Summit.
Dr. Pratik Sandesara is an interventional cardiologist at Emory University Hospital and an assistant professor of...
Dr. Pratik Sandesara is an interventional cardiologist at Emory University Hospital and an assistant professor of medicine at Emory University School of Medicine. His clinical focus is on complex and high-risk percutaneous coronary intervention including chronic total occlusion revascularization.
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional...
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.